Keywords: pdl, shares, plunge, firm, ends, sale, process

PDL shares plunge 32% as firm ends sale process

Article | 17 March 2008

Print This

Shares in PDL BioPharma plunged 32%, after the US biotechnology firm decided to take itself off the market (Marketletters passim). Although ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in